Optimae Lifeservices,inc. - Medicare Mental Health Clinic in Muscatine, IA

Optimae Lifeservices,inc. is a medicare enrolled mental health clinic (Community/behavioral Health) in Muscatine, Iowa. The current practice location for Optimae Lifeservices,inc. is 3500 Harmony Ct, Muscatine, Iowa. For appointments, you can reach them via phone at (563) 263-5585. The mailing address for Optimae Lifeservices,inc. is 301 W Burlington Ave, Fairfield, Iowa and phone number is (641) 472-1684.

Optimae Lifeservices,inc. is licensed to practice in Iowa (license number CMHC). The clinic also participates in the medicare program and its NPI number is 1184898470. This medical practice accepts medicare insurance (which means this clinic accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance). However, please confirm if they accept your insurance at (563) 263-5585.

Contact Information

Optimae Lifeservices,inc.
3500 Harmony Ct
Muscatine
IA 52761-5700
(563) 263-5585
(563) 263-8610

Mental Health Clinic Profile

Full NameOptimae Lifeservices,inc.
SpecialityCommunity/Behavioral Health
Location3500 Harmony Ct, Muscatine, Iowa
Authorized Official Name and PositionRod Hotek (CEO)
Authorized Official Contact6414721684
Accepts Medicare InsuranceYes. This clinic participates in medicare program and accept medicare insurance.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Optimae Lifeservices,inc.
301 W Burlington Ave
Fairfield
IA 52556-3242

Ph: (641) 472-1684
Optimae Lifeservices,inc.
3500 Harmony Ct
Muscatine
IA 52761-5700

Ph: (563) 263-5585

NPI Details:

NPI Number1184898470
Provider Enumeration Date04/17/2008
Last Update Date10/28/2013

Medicare PECOS Information:

Medicare PECOS PAC ID8022912211
Medicare Enrollment IDO20031120000270

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Medical Identifiers

Medical identifiers for Optimae Lifeservices,inc. such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1184898470NPI-NPPES
600482882OtherIAIOWA PLAN MIS SITE

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
251S00000XCommunity/behavioral Health CMHC (Iowa)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Optimae Lifeservices,inc. acts as a billing entity for following providers:
Provider NameLuanne D Johnson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1922096601
PECOS PAC ID: 1052302106
Enrollment ID: I20040519000431

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameEdward J Rund
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1831138635
PECOS PAC ID: 6507760071
Enrollment ID: I20040825001296

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameSara A Hopkins
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1609948504
PECOS PAC ID: 4385674829
Enrollment ID: I20050815001048

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameMelissa Eastman Huff
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1174535793
PECOS PAC ID: 2860498524
Enrollment ID: I20061020000080

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameEva F Ford
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1891704219
PECOS PAC ID: 1355343815
Enrollment ID: I20070213000160

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameStephen E Prettyman
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1417077264
PECOS PAC ID: 0446341622
Enrollment ID: I20070801000680

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameJuliet A Bles
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1245495027
PECOS PAC ID: 5698834406
Enrollment ID: I20081110000033

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameRebecca J Schmitz
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1518163120
PECOS PAC ID: 9931388477
Enrollment ID: I20110128001002

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameKimberly J Brown
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1013286020
PECOS PAC ID: 4486813037
Enrollment ID: I20120316000672

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameLisa Renee Kongable
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1336158666
PECOS PAC ID: 9335301209
Enrollment ID: I20120510000561

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameMeredith D Olson
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1801131461
PECOS PAC ID: 7416193859
Enrollment ID: I20130409000614

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameKiran Annam
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1477993830
PECOS PAC ID: 7618110958
Enrollment ID: I20130905000388

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameRochelle M Phelps
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1497933741
PECOS PAC ID: 8527297183
Enrollment ID: I20140131001468

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NamePatty S Huebner-vaughan
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1659627552
PECOS PAC ID: 2062732001
Enrollment ID: I20150514002736

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameLisa A Rock
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1487908380
PECOS PAC ID: 8022325174
Enrollment ID: I20150922001517

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameSara E Kuhn
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1225414576
PECOS PAC ID: 0547578767
Enrollment ID: I20151007001606

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NamePatricia Gail Kirkpatrick
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1508238635
PECOS PAC ID: 6901108604
Enrollment ID: I20160113000443

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameTeresa E Seward
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1770502668
PECOS PAC ID: 1052315017
Enrollment ID: I20160517002310

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameDenise L Stutes
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1497119994
PECOS PAC ID: 9638461338
Enrollment ID: I20160715000849

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameLily E Peterson Williby
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1235426529
PECOS PAC ID: 2668756776
Enrollment ID: I20170308001416

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameDenise L Kelley Edwards
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1730615881
PECOS PAC ID: 7315214426
Enrollment ID: I20170522000164

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameTravis M Underwood
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1811307903
PECOS PAC ID: 4688944721
Enrollment ID: I20170721000972

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameDianne H Kobberdahl
Provider TypePractitioner - Occupational Therapist In Private Practice
Provider IdentifiersNPI Number: 1841717204
PECOS PAC ID: 1951674175
Enrollment ID: I20170908002032

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameLu Andich Evergreen
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1487156154
PECOS PAC ID: 0749542116
Enrollment ID: I20180322002011

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameCharlotte L Kraai
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1649389818
PECOS PAC ID: 2567701352
Enrollment ID: I20190221001833

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameClaudia V Mast
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1194296905
PECOS PAC ID: 2264768795
Enrollment ID: I20190722002895

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameLauren E Flynn
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1881253631
PECOS PAC ID: 3072949692
Enrollment ID: I20200130000710

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameAngela K Dossett
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1609496033
PECOS PAC ID: 7113348996
Enrollment ID: I20200603000608

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameRenee M Socarras
Provider TypePractitioner - Occupational Therapist In Private Practice
Provider IdentifiersNPI Number: 1679180780
PECOS PAC ID: 8729499108
Enrollment ID: I20201117000987

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameSusan R Fowler
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1578029211
PECOS PAC ID: 6204225006
Enrollment ID: I20211117000997

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameDanielle M Van Oosbree
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1184395162
PECOS PAC ID: 9133510233
Enrollment ID: I20211228001628

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameKatherine J Lowary
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1336853415
PECOS PAC ID: 7214300219
Enrollment ID: I20230222000467

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameJoanna Esker
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1992210470
PECOS PAC ID: 5799140240
Enrollment ID: I20230505000573

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameTory A Keyser
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1700379955
PECOS PAC ID: 2062768690
Enrollment ID: I20230520000258

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameMarie I Brickner
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1790499648
PECOS PAC ID: 2769840446
Enrollment ID: I20230628001856

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameStephanie Baumhover
Provider TypePractitioner - Clinical Social Worker
Provider IdentifiersNPI Number: 1396329561
PECOS PAC ID: 4789048919
Enrollment ID: I20230906004132

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameLizabeth Sheets
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1144900861
PECOS PAC ID: 9537516190
Enrollment ID: I20231103002660

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameSuzanna E Mullenneaux
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1134215197
PECOS PAC ID: 3870943640
Enrollment ID: I20231220002697

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameTeresa A Pappas
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1184744955
PECOS PAC ID: 6204286909
Enrollment ID: I20231221000325

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameJoslyn M Behnken
Provider TypePractitioner - Mental Health Counselor
Provider IdentifiersNPI Number: 1841691177
PECOS PAC ID: 7810347895
Enrollment ID: I20240103002797

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

Provider NameLisa S Sotelo
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1598542383
PECOS PAC ID: 6305298548
Enrollment ID: I20240123004105

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more Medical News

› Verified 4 days ago

News Archive

FASEB MARC Program announces recipients of travel award

FASEB MARC (Maximizing Access to Research Careers) Program has announced the travel award recipients for the American College of Sports Medicine's Conference on Integrative Physiology of Exercise from September 17-20, 2014 in Miami, Florida.

DTI assessment indicates that mild hypothermia therapy may be beneficial for patients with diffuse axonal injury

Mild hypothermia has been shown to exert apparent neuroprotective effects in animal models of diffuse axonal injury. However, the clinical efficacy of mild hypothermia is controversial.

Idera reports $6.0 million net loss for fourth quarter 2010

Idera Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2010.

Dementia decline heralds hope of reduced burden

Analysis of participants in the Framingham Heart Study has shown a decline in dementia over a period of 3 decades.

Dendreon second-quarter revenue increases to $2.8 million

Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.

Read more News

› Verified 4 days ago

Community/Behavioral Health in Muscatine, IA

Rescare, Inc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1810 Houser St, Muscatine, IA 52761
Phone: 563-263-5594    Fax: 563-262-4007
Sunrise Enterprise Llc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2925 Cedar St Ste 2, Muscatine, IA 52761
Phone: 563-263-7410    Fax: 563-263-7506
New Horizons
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 1605 Cedar St, Suite B, Muscatine, IA 52761
Phone: 563-264-9118    
Pearl City Psychiatry, Pllc
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 228 W 2nd St, Muscatine, IA 52761
Phone: 563-278-2796    
The Robert Young Center For Community Mental Health
Mental Health Clinic
Medicare: Medicare Enrolled
Practice Location: 1616 Cedar St, Muscatine, IA 52761
Phone: 309-779-2022    
Allied Therapies, Pc
Mental Health Clinic
Medicare: Not Enrolled in Medicare
Practice Location: 2925 Cedar St, Muscatine, IA 52761
Phone: 563-264-2222    Fax: 563-264-2222

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.